Evidence map›Paper›PMID 41454398›Full record

ArticleThrombosis journal2025

A pedigree analysis of deep venous thrombosis caused by rare compound heterozygous PROC mutations combined with a heterozygous THBD mutation.

Rui Tuo, Lixuan Chen, Xingxian Xiao, Qinglin Mo, Chaolin Chen, Chang Su, Ying Feng, Yang Xiao

Abstract read
In one paragraph

Article in Thrombosis journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rui Tuo *Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
Lixuan Chen *Department of Hematology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, No.128 Shekou Industrial Seventh Road, Nanshan District, Shenzhen, Guangdong, 518067, China.
Xingxian XiaoDepartment of Hematology, Jiangmen Central Hospital, Jiangmen, Guangdong, 529030, China.
Qinglin MoDepartment of Hematology, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510000, China.
Chaolin ChenHemostasis & Thrombus Lab, Guangzhou Zhili Medicine, Guangzhou, Guangdong, 510700, China.
Chang SuHemostasis & Thrombus Lab, Guangzhou Zhili Medicine, Guangzhou, Guangdong, 510700, China.
Ying FengHemostasis & Thrombus Lab, Guangzhou Zhili Medicine, Guangzhou, Guangdong, 510700, China. fyzlply@163.com.
Yang XiaoGuangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China. jdxiao111@163.com.ORCID http://orcid.org/0000-0003-0046-4967

Funding

Shenzhen Clinical Research Center for hematologic disease LCYSSQ20220823091401002the Major Science and Technology projects of Shenzhen Municipal Nanshan District Health System No. NSZD2023054
6 · The paper itself

Abstract

Venous thromboembolism is a common fatal disease that includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and many genetic risk factors are associated with its pathogenesis. We describe a patient with compound heterozygous mutations in PROC combined with a heterozygous mutation in THBD, who was diagnosed with DVT. Genetic sequencing identified three missense mutations in the proband: PROC c.565 C > T (p.R189W), PROC c.1218G > A (p.M406I), and THBD c.1456G > T (p.D486Y), this genotype not previously documented in association with thrombotic disease. His father carried heterozygous mutations of PROC p.R189W and THBD p.D486Y, while his mother and maternal grandfather were heterozygous for PROC p.M406I. These mutations were not detected in other family members.

Indexed as

Compound heterozygous mutationDeep vein thrombosis (DVT)Protein c deficiencyThrombomodulin

Identifiers

PMID41454398
PMCPMC12849342

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.